rs749237778
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000639.3(FASLG):βc.153_158delβ(p.Pro52_Pro53del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,610,614 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 32)
Exomes π: 0.000016 ( 0 hom. )
Consequence
FASLG
NM_000639.3 inframe_deletion
NM_000639.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.54
Genes affected
FASLG (HGNC:11936): (Fas ligand) This gene is a member of the tumor necrosis factor superfamily. The primary function of the encoded transmembrane protein is the induction of apoptosis triggered by binding to FAS. The FAS/FASLG signaling pathway is essential for immune system regulation, including activation-induced cell death (AICD) of T cells and cytotoxic T lymphocyte induced cell death. It has also been implicated in the progression of several cancers. Defects in this gene may be related to some cases of systemic lupus erythematosus (SLE). Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 24 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASLG | NM_000639.3 | c.153_158del | p.Pro52_Pro53del | inframe_deletion | 1/4 | ENST00000367721.3 | NP_000630.1 | |
FASLG | NM_001302746.2 | c.153_158del | p.Pro52_Pro53del | inframe_deletion | 1/3 | NP_001289675.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASLG | ENST00000367721.3 | c.153_158del | p.Pro52_Pro53del | inframe_deletion | 1/4 | 1 | NM_000639.3 | ENSP00000356694 | P1 | |
FASLG | ENST00000340030.4 | c.153_158del | p.Pro52_Pro53del | inframe_deletion | 1/3 | 1 | ENSP00000344739 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151750Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151750
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244282Hom.: 0 AF XY: 0.00000754 AC XY: 1AN XY: 132564
GnomAD3 exomes
AF:
AC:
3
AN:
244282
Hom.:
AF XY:
AC XY:
1
AN XY:
132564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1458864Hom.: 0 AF XY: 0.0000179 AC XY: 13AN XY: 725636
GnomAD4 exome
AF:
AC:
24
AN:
1458864
Hom.:
AF XY:
AC XY:
13
AN XY:
725636
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151750Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74110
GnomAD4 genome
AF:
AC:
4
AN:
151750
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74110
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autoimmune lymphoproliferative syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2021 | This variant, c.153_158del, results in the deletion of 2 amino acid(s) of the FASLG protein (p.Pro52_Pro53del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs770888162, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with FASLG-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at